Searching the Resource Information Network

Our searching services are busy right now. Please try again later

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes

Single-Cell Transcriptomics Identifies the Adaptation of Scart1+ Vγ6+ T Cells to Skin Residency as Activated Effector Cells.

Likai Tan | Inga Sandrock | Ivan Odak | Yuval Aizenbud | Anneke Wilharm | Joana Barros-Martins | Yaara Tabib | Alina Borchers | Tiago Amado | Lahiru Gangoda | Marco J Herold | Marc Schmidt-Supprian | Jan Kisielow | Bruno Silva-Santos | Christian Koenecke | Avi-Hai Hovav | Christian Krebs | Immo Prinz | Sarina Ravens
Cell reports | 2019

IL-17-producing γδ T cells express oligoclonal Vγ4+ and Vγ6+ TCRs, mainly develop in the prenatal thymus, and later persist as long-lived self-renewing cells in all kinds of tissues. However, their exchange between tissues and the mechanisms of their tissue-specific adaptation remain poorly understood. Here, single-cell RNA-seq profiling identifies IL-17-producing Vγ6+ T cells as a highly homogeneous Scart1+ population in contrast to their Scart2+ IL-17-producing Vγ4+ T cell counterparts. Parabiosis demonstrates that Vγ6+ T cells are fairly tissue resident in the thymus, peripheral lymph nodes, and skin. There, Scart1+ Vγ6+ T cells display tissue-specific gene expression signatures in the skin, characterized by steady-state production of the cytokines IL-17A and amphiregulin as well as by high expression of the anti-apoptotic Bcl2a1 protein family. Together, this study demonstrates how Scart1+ Vγ6+ T cells undergo tissue-specific functional adaptation to persist as effector cells in their skin habitat.

Pubmed ID: 31216482

Additional research tools detected in this publication

None found

Associated grants

None

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Anti-TCR?-APC-Vio770, mouse (antibody)

RRID:AB_2654026

This monoclonal targets TCR?

View all literature mentions

Anti-TCRβ-PerCP-Vio700 (antibody)

RRID:AB_2654028

This monoclonal targets TCR?

View all literature mentions

PE/Cyanine7 anti-mouse CD3epsilon (antibody)

RRID:AB_312685

This monoclonal targets CD3epsilon

View all literature mentions

CD279 (PD-1) (antibody)

RRID:AB_2737634

This monoclonal targets CD279 (PD-1)

View all literature mentions

APC anti-mouse TCR gamma/delta (antibody)

RRID:AB_1731813

This monoclonal targets TCR gamma/delta

View all literature mentions

B6.129S4-Ifngtm3.1Lky/J (organism)

RRID:IMSR_JAX:017581

Mus musculus with name B6.129S4-Ifngtm3.1Lky/J from IMSR.

View all literature mentions

C57BL/6-Trdctm1Mal/J (organism)

RRID:IMSR_JAX:016941

Mus musculus with name C57BL/6-Trdctm1Mal/J from IMSR.

View all literature mentions

B6.129S-Tcrdtm1.1(cre/ERT2)Zhu/J (organism)

RRID:IMSR_JAX:031679

Mus musculus with name B6.129S-Tcrdtm1.1(cre/ERT2)Zhu/J from IMSR.

View all literature mentions